JPS4954517A - - Google Patents

Info

Publication number
JPS4954517A
JPS4954517A JP48032537A JP3253773A JPS4954517A JP S4954517 A JPS4954517 A JP S4954517A JP 48032537 A JP48032537 A JP 48032537A JP 3253773 A JP3253773 A JP 3253773A JP S4954517 A JPS4954517 A JP S4954517A
Authority
JP
Japan
Prior art keywords
macroprotein
denatured
divalent tin
injectable suspension
macroaggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48032537A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5328971B2 (enrdf_load_stackoverflow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4954517A publication Critical patent/JPS4954517A/ja
Publication of JPS5328971B2 publication Critical patent/JPS5328971B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3253773A 1972-03-20 1973-03-20 Expired JPS5328971B2 (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US236159A US3863004A (en) 1972-03-20 1972-03-20 Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation

Publications (2)

Publication Number Publication Date
JPS4954517A true JPS4954517A (enrdf_load_stackoverflow) 1974-05-27
JPS5328971B2 JPS5328971B2 (enrdf_load_stackoverflow) 1978-08-17

Family

ID=22888369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3253773A Expired JPS5328971B2 (enrdf_load_stackoverflow) 1972-03-20 1973-03-20

Country Status (10)

Country Link
US (1) US3863004A (enrdf_load_stackoverflow)
JP (1) JPS5328971B2 (enrdf_load_stackoverflow)
AU (1) AU472255B2 (enrdf_load_stackoverflow)
BE (1) BE796962A (enrdf_load_stackoverflow)
DE (1) DE2314059A1 (enrdf_load_stackoverflow)
FR (1) FR2182880B1 (enrdf_load_stackoverflow)
GB (1) GB1409176A (enrdf_load_stackoverflow)
IL (1) IL41767A (enrdf_load_stackoverflow)
IT (1) IT989625B (enrdf_load_stackoverflow)
NL (1) NL7303842A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53127809A (en) * 1977-04-01 1978-11-08 New England Nuclear Corp Alubmin containing diagnostic agent and production thereof
JPH05271102A (ja) * 1991-04-09 1993-10-19 Merck Frosst Canada Inc 放射性薬剤の制菌剤

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968221A (en) * 1972-05-05 1976-07-06 Medi-Physics, Inc. 99M-Technetium labeled tin colloid radiopharmaceuticals
US4024233A (en) * 1972-06-05 1977-05-17 Medi-Physics, Inc. 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
GB1535847A (en) * 1976-03-19 1978-12-13 Radiochemical Centre Ltd Technetium-99m labelled tin colloid for body scanning
US4226846A (en) * 1977-04-01 1980-10-07 New England Nuclear Corporation Albumin microaggregates for radioactive scanning of reticuloendothelial systems
US4337240A (en) * 1978-04-20 1982-06-29 New England Nuclear Corporation Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems
EP0024464B1 (en) * 1979-08-29 1982-05-12 Nihon Medi-Physics Co., Ltd. 2-oxopropionaldehyde bis(thiosemicarbazone)derivatives and their production and use
JPS5645790U (enrdf_load_stackoverflow) * 1979-09-17 1981-04-24
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
CH652599A5 (de) * 1981-08-28 1985-11-29 Solco Basel Ag Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung.
JPS61103841A (ja) * 1984-10-26 1986-05-22 Nippon Mejifuijitsukusu Kk 放射性テクネチウム標識に供する安定な塩化第一スズ組成物
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5071965A (en) * 1988-07-19 1991-12-10 Mallinckrodt Medical, Inc. Novel tc-99m complexes
US5096696A (en) * 1990-02-05 1992-03-17 The Research Foundation Of State University Of New York Binding of radiolabeled albumin fragments to fibrin clots
US5137709A (en) * 1991-02-15 1992-08-11 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
WO1993016735A1 (en) * 1992-02-28 1993-09-02 Order Stanley E Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
DE10317461A1 (de) * 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
FI20040240A0 (fi) * 2004-02-13 2004-02-13 Nokia Corp Laskutusinformaation tuottaminen viestintäjärjestelmässä

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4839546A (enrdf_load_stackoverflow) * 1971-07-20 1973-06-11

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663686A (en) * 1968-04-24 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US3663687A (en) * 1968-06-26 1972-05-16 Minnesota Mining & Mfg Biodegradable parenteral microspherules
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4839546A (enrdf_load_stackoverflow) * 1971-07-20 1973-06-11

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53127809A (en) * 1977-04-01 1978-11-08 New England Nuclear Corp Alubmin containing diagnostic agent and production thereof
JPH05271102A (ja) * 1991-04-09 1993-10-19 Merck Frosst Canada Inc 放射性薬剤の制菌剤

Also Published As

Publication number Publication date
FR2182880B1 (enrdf_load_stackoverflow) 1976-04-09
IT989625B (it) 1975-06-10
DE2314059A1 (de) 1973-10-04
BE796962A (fr) 1973-09-19
IL41767A0 (en) 1973-05-31
IL41767A (en) 1976-06-30
GB1409176A (en) 1975-10-08
JPS5328971B2 (enrdf_load_stackoverflow) 1978-08-17
AU472255B2 (en) 1976-05-20
FR2182880A1 (enrdf_load_stackoverflow) 1973-12-14
NL7303842A (enrdf_load_stackoverflow) 1973-09-24
US3863004A (en) 1975-01-28
AU5337573A (en) 1974-09-19

Similar Documents

Publication Publication Date Title
FR2182880B1 (enrdf_load_stackoverflow)
NZ210194A (en) Pentapeptides with thymopoietin and splenin like activity
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
BE807223A (fr) Conteneur d'expedition et de distributions
NL980006I1 (nl) Antigeen-preparaten en isolering van dergelijke preparaten.
IE36847L (en) 7, 7-disubtituted cephalosporins and 6, 6-disubtituted¹penicillins
BR7906157A (pt) Aperfeicoamento em processo para a cura de uma composicao de poliester insaturado, composicao de resina, sistema acelerador para composicoes de resina e composto de sal de metal
ES408177A1 (es) Un metodo de manufactura de un medio preservativo de la sangre mejorado.
GB1029441A (en) Rubber mixtures
IL58103A (en) Sila-substituted 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
CH550203A (de) Verfahren zur herstellung von in c8-stellung modifizierten purinribofuranosid-3' :5'-cyclophosphaten und deren verwendung.
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
EG10761A (en) Process for preparing new substituted 1,3-diamino guanidies useful in the prevention and control of poultry coccodiosis
FR2108935A1 (en) Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals
JPS51128349A (en) Reinforled polyacetal resin composition and method of preparing the sa me
SE329175B (enrdf_load_stackoverflow)
CH556358A (de) Verfahren zur herstellung von 2,6-dialkylphenolen und deren verwendung.
CS183037B1 (en) Agent for destroying weeds in pine cultures and other conifers
SE8404130L (sv) Nya injecerbara kompositioner
GB1263848A (en) A particulate composition for use in meat curing media and method of preparing same
WANG et al. Effects of endotoxin on calcium and calcium-calmodulin complex in endothelial cells
JPS55131077A (en) Organic filler obtained from animal as low abrasiveness friction material
Gusev et al. Investigation of the Hall Effect and Structure Defects in Ge Irradiated With 30-keV Ga Plus Ions
Kolb et al. Recovery From Radiation Injury After Maximal Doses of Fractionated Total and Partial Body Irradiation and Bone Marrow Transplantation.